“It’s really hard to learn to swim when you’re already drowning.” — Courtney Gidengil, MD, MPH, of the RAND Corporation in Boston, on a pandemic-era peer-to-peer intervention to boost clinician well-being.
“Critically appraise everything, regardless of origin.” — Dennis Ren, MD, of the Children’s National Hospital in Washington, discussing research abstracts written by artificial intelligence.
“It’s a question of when, rather than if, we lose that last antibiotic.” — Jonathan Ross, MD, of the University of Birmingham in England, on the urgent need for more gonorrhea-treating oral antibiotics.
“Antivirals are by no means a panacea.” — William Schaffner, MD, of Vanderbilt University Medical Center in Nashville, Tennessee, on using current antivirals if the avian flu adapts to humans.
“I would not be confident on relying on any of these tests.” — Ruth Hogg, PhD, of Queen’s University Belfast in Ireland, on at-home age-related macular degeneration vision tests.
“Nurses should not be held criminally liable for a mere mistake.” — Nancy Galvagni, president and chief executive officer of the Kentucky Hospital Association, after Kentucky became the first state to decriminalize medical errors.
“This is an incredibly exciting time in schizophrenia research.” — David Walling, PhD, of CenExel in Garden Grove, California, on the phase III findings of the novel drug combination.
“The previously proposed version of this LDT rule did not have that giant, deadly loophole.” — Diana Zuckerman, PhD, president of the National Center for Health Research in Washington, D.C., critiquing the FDA’s final rule to regulate laboratory-developed tests (LDTs).
Please enable JavaScript to view the